Subscribe To
Why 2023 could be a tough year for abbvie stock
Humira's sales are forecast to fall by 37% this year. It may be years before Skyrizi and Rinvoq can make up for the Humira sales drop....
April 12, 2023, 5:15 am
Final trades: starbucks, abbvie, microsoft & apa corp.
The final trades of the day. With CNBC's Melissa Lee and the Fast Money traders....
April 11, 2023, 6:35 pm
abbvie (abbv), j&j to withdraw 2 blood cancer nods for imbruvica
abbvie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two bloo...
April 10, 2023, 12:09 pm
abbvie lowers guidance after $150 million charge
abbvie Inc. ABBV, +0.64% late Wednesday lowered its guidance for the year to include a charge of about ...
April 5, 2023, 5:21 pm
Final trades: abbvie, thermo fisher & more
The "Halftime Report" traders give their top picks to watch for the second half....
April 5, 2023, 1:57 pm
Better dividend stock: abbvie vs. johnson & johnson
Both healthcare giants are among the most elite dividend stocks on the market. abbvie can handle the bi...
April 5, 2023, 8:55 am
Want to collect big dividends each month? buy these 3 stocks
abbvie's drug portfolio and pipeline bode well for future growth. Consumers value experiences more than...
April 5, 2023, 6:10 am
abbvie inc. (abbv) is attracting investor attention: here is what you should know
abbvie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth explor...
April 3, 2023, 10:39 am
Could this drug news lift abbvie's stock?
Rinvoq recently moved into phase 3 clinical trials for what could be its seventh indication. If approved, it could generate almost $400 million in add...
April 1, 2023, 9:15 am
This blockbuster drug's latest news could be another home run for abbvie
Skyrizi's recently announced phase 3 clinical trial results to treat ulcerative colitis demonstrate that it is effective. An ulcerative colitis indica...
March 31, 2023, 8:50 am
Better growth stock: vertex pharmaceuticals vs. abbvie
Vertex and abbvie both beat the bear market last year. Both these top companies have reached an importa...
March 29, 2023, 2:00 pm
Better growth stock: abbvie vs. pfizer
abbvie might not grow much in 2023 and 2024. Pfizer will see tens of billions of its sales evaporate so...
March 29, 2023, 7:30 am
2 relatively safe dividend stocks you won't regret owning
Companies that hike their dividends over and over tend to be financially healthy. abbvie's good track r...
March 28, 2023, 10:07 am
Better buy: abbvie vs. johnson & johnson
abbvie and J&J both are facing big transitions this year. These stocks look inexpensive today, both tra...
March 25, 2023, 5:30 am
abbvie (abbv) provides clinical updates on inflammatory drugs
abbvie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus ery...
March 24, 2023, 2:28 pm
Final trades: abbvie, nike, fedex & more
The "Halftime Report" traders give their top picks to watch for the second half....
March 23, 2023, 2:26 pm
2 reasons to buy abbvie, and 1 reason to sell
abbvie's top-selling drug is facing competition -- and lower revenue. The company still has much to off...
March 23, 2023, 5:30 am
abbvie inc. (abbv) is a trending stock: facts to know before betting on it
Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...
March 22, 2023, 10:44 am
Schd: your complete guide to the march 2023 index reconstitution
Schwab U.S. Dividend Equity ETF's Index underwent its annual reconstitution at business close Friday. A total of 25 companies were added, namely ...
March 21, 2023, 3:24 pm
abbvie: comparing the current valuation to its last growth cycle
abbvie is one of the most prominent biotechnology/healthcare stocks known for paying a good dividend. B...
March 14, 2023, 12:43 pm